My son was diagnosed with type 1 diabetes at the age of 13.Which is why this episode is very close to my heart. There are big life-altering challenges for the patient and their family in managing type 1 diabetes. With limitations to the current insulin therapies that make the work of my guest in the episode, Mike Teiler, all the more important.Mike is the Chief Pharmaceutical Officer at LeviCure, a startup focused on new approaches to type 1 diabetes. In this episode we discuss the difference between type 1 and type 2 diabetes. And explore the development of LeviCure's triple therapy, which combines three existing drugs to improve glycaemic control and potentially achieve remission in type 1 diabetes patients.A therapy that has shown promising results in both recent onset and established patients. We discuss the potential of repurposing existing drugs for the treatment of type 1 diabetes. As well as the funding required and the clinical trial process that will be undertaken to be able to launch the therapy.“Many of them completely stopped insulin injections.” – Mike TeilerYou’ll hear about:01:10 - The difference between type & type 2 diabetes04:03 - The lifechanging nature of type 1 diabetes06:40 - The LeviCure story11:16 - The effect of weening people off of insulin 15:08 - Oral drugs that could replace insulin18:48 - Disentangling the honeymoon effect20:15 - The effects on established patients                 25:02 - The pharmaceutical benefits of this therapy27:58 - The intellectual property perspective30:43 - The democratic nature of these new therapies34:15 - What are the clinical phases?41:08 - Making sure the therapies hit the target43:44 - The fundraising needed Follow Mike: LinkedIn - https://www.linkedin.com/in/miketeiler/ LeviCure on LinkedIn - https://www.linkedin.com/company/levicure-ltd/ LeviCure - https://www.levicure.com/  Connect with me:LinkedIn: https://www.linkedin.com/in/markdavison100/ Grant Instruments: https://www.grantinstruments.com/ Grant Instruments on LinkedIn: https://www.linkedin.com/company/grant-instruments-cambridge-ltd/ 

Ver todos los episodios